Physics for practitioners: The use of radiolabeled monoclonal antibodies in B-Cell non-Hodgkin's lymphoma
- 31 October 2000
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 37, 2-8
- https://doi.org/10.1016/s0037-1963(00)90054-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP ChemotherapyJournal of Clinical Oncology, 1999
- Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1998
- Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.Journal of Clinical Oncology, 1998
- Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphomaAnnals of Oncology, 1998
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998
- Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.Journal of Clinical Oncology, 1996
- Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1993
- Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.Journal of Clinical Oncology, 1992
- Treatment of Lymphoma With Radiolabeled Antibody: Elimination of Tumor Cells Lacking Target AntigenJNCI Journal of the National Cancer Institute, 1990
- Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomasBlood, 1987